Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-26 10:53:12 - browse：97579

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

WSS

UnitedHealth wins $3.3 billion takeover of Amedisys

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

HIV vaccine remains elusive. Immunologists keep trying new ideas

Cytokinetics CEO stresses company can launch heart drug on its own

Data integrity in scientific journals requires "effort" by publishers, institutions

knowledge

Wikipedia

hotspot

Hollywood unions extend contract negotiations for actors

UnitedHealth wins $3.3 billion takeover of Amedisys

BioMarin wins approval for gene therapy to treat hemophilia A

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Psychedelics group wrestles with new pharma identity

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Virginia high school admissions case could be legal follow

Medical experts exlpore how to eliminate bias in clinical algorithms

Novavax promises a turnaround & Lilly roils the obesity market

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

hotspot

Criminal prosecution for violating HIPAA: an emerging threat

NVIDIA and Google execs on the future of AI and drug discovery

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Cytokinetics CEO stresses company can launch heart drug on its own

Arc Institute generative AI designs new CRISPR systems

Big Tobacco's 'harm reduction': Is it for real, or a sham?

hotspot

knowledge

focus

focus